To address whether alterations in checkpoint molecules in IDO-deficient mice would be recapitulated in response to combination therapy, we analyzed CD8+ lymphocytes within the tumor for immune checkpoint molecules PD-1, CTLA-4, LAG-3, and TIM-3. Here, IDO1 is linked to neoplasm.